Ownership history in UBS Group AG · 22 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in ESSA PHARMA INC (EPIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 5,473 | -6,548 | -54.5% | 0.00% | $1K | — |
| 2025 Q2 | REDUCED | 12,021 | -11,587 | -49.1% | 0.00% | $20K | — |
| 2025 Q1 | REDUCED | 23,608 | -72,006 | -75.3% | 0.00% | $37K | — |
| 2024 Q4 | ADDED | 95,614 | +93,197 | +3855.9% | 0.00% | $171K | — |
As of 2025 Q3 — sorted by position size